AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wootton-Gorges, S. L.
Right arrow Articles by Glaser, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wootton-Gorges, S. L.
Right arrow Articles by Glaser, N.

Detection of Cerebral ß-Hydroxy Butyrate, Acetoacetate, and Lactate on Proton MR Spectroscopy in Children with Diabetic Ketoacidosis

Sandra L. Wootton-Gorgesa, Michael H. Buonocorea, Nathan Kuppermannb,c, James Marcinb, Joseph DiCarlod, E. Kirk Neelyd, Patrick D. Barnese and Nicole Glaserb

a Department Radiology, University of California, Davis School of Medicine
b Department Pediatrics, University of California, Davis School of Medicine
c Department Internal Medicine, Division of Emergency Medicine{ddagger}, University of California, Davis School of Medicine
d Department of Pediatrics, Stanford University School of Medicine
e Radiology, Stanford University School of Medicine



View larger version (95K):

[in a new window]
 
FIG 1. Position of voxels for spectroscopy in the periaqueductal region (A) and in the basal ganglia (B).



View larger version (31K):

[in a new window]
 
FIG 2. Patients with ßOHB, AcAc, both, or neither on initial imaging during DKA therapy.



View larger version (27K):

[in a new window]
 
FIG 3. Findings in a 3-year-old girl with new-onset DKA.

A, Initial spectra were obtained 2 hours after the start of therapy for DKA (black) in the patient and a phantom containing only ßOHB (gray). ßOHB is seen as a doublet centered at 1.2 ppm.

B, ßOHB is absent in the patient’s spectrum (black) obtained after her recovery from DKA.



View larger version (34K):

[in a new window]
 
FIG 4. Patients with ßOHB and/or AcAc on initial imaging by the timing of the study after the start of therapy.



View larger version (17K):

[in a new window]
 
FIG 5. Findings in a 14-year-old male adolescent; arb indicates arbitrary.

A, Initial spectrum (black) during DKA shows AcAc (peak at 2.22 ppm) and ßOHB. Spectrum from the phantom containing ßOHB is gray.

B, On the spectrum obtained after the patient’s recovery from DKA, AcAc and ßOHB are absent.

C, Difference spectrum between A and B.



View larger version (27K):

[in a new window]
 
FIG 6. Findings in an 11-year-old girl with DKA.

A, Initial spectrum (black) during treatment for DKA and spectrum from phantom containing both lactate and ßOHB (gray). Patient’s spectrum shows lactate and ßOHB as a triplet with peaks from 1.15 to 1.38 ppm. AcAc is noted at 2.22–2.26 ppm.

B, After recovery, no lactate or ßOHB is detected on the patient’s spectrum (black).